Clinical trials were a lifeline for Rebecca. Over the course of the seven years she lived with advanced melanoma, she participated in three trials, the last of which probably added at least one year of quality time to her life.
A dozen new treatments for melanoma have been approved by the FDA since the year Rebecca died, and that number continues to grow. Clinical trials are key to our progress. There are currently more than 300 melanoma-focused clinical trials recruiting more than 80,000 patients. Yet only one in 20 cancer patients is now enrolled in a clinical trial.
Clinical trials are testing new therapies, studying the ways that melanoma develops and metasticizes, and looking at genomic and other factors that can help determine which treatment is best for which patient. They also offer you the patient the opportunity to receive cutting edge treatments not yet approved by the FDA. If you are a melanoma patient and you possibly can, you should be enrolled in a trial.
Finding a trial has never been easier than with Antidote's new Clinical Trial Navigator. Get started below to find a trial that's right for you.